Actively Recruiting
Study of Lithium to Prevent Thinking Problems After Brain Radiation in Children and Teens
Led by Region Stockholm · Updated on 2024-04-12
84
Participants Needed
2
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether taking oral lithium tablets for six months can help prevent cognitive decline in children who have undergone brain radiotherapy for brain tumors. This randomized, placebo-controlled, double-blinded study focuses on pediatric brain tumor survivors aged 5 years and older, investigating the effect of lithium on cognitive processing speed measured two years after starting treatment. Participants will receive either lithium sulphate tablets or identical placebo tablets. The lithium dose starts at 42 mg once daily and is gradually increased to maintain a target blood level between 0.5 and 1.0 mmoll, using therapeutic drug monitoring. Placebo dosing follows a similar schedule with sham monitoring. The study treatment lasts for up to seven years, including ongoing evaluation of cognitive function and brain imaging. During the study, participants will undergo regular neuropsychological tests, quality of life assessments, and brain MRI scans from baseline through up to five years after treatment begins. Researchers will monitor side effects and laboratory tests to assess safety and tolerability. The main outcome measured is the Processing Speed Index two years after treatment starts, with additional cognitive and behavioral tests conducted over the longer term. Participant involvement includes scheduled visits and assessments during and after treatment to monitor cognitive health and overall well-being.
CONDITIONS
Brief Title
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Research Team
K
Klas Blomgren, MD, Professor
G
Gustaf Hellspong, MD, PhD Student
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here